Tracking Medicare news, policy, and coverage changes.
Hospitals can prevent medical debt by preemptively wiping out a patient’s bill. But a Tradeoffs analysis finds that few nonprofit facilities in Texas use this tool to the maximum benefit of patients.
Read full article →On Wall Street, the real trouble for biotech, and the reason for investor angst, lies below the surface.
Read full article →About 40% of high school students reported binge-eating in the past month in a new CDC survey, highlighting how widespread this form of disordered eating is among young people.
Read full article →Want to opt out of sharing your personal health data? You may need a notary, writes Alex Rosenblat.
Read full article →Health systems invest in training, but lose early-career nurses within a few years.
Read full article →Cold and flu season is here. Before someone in your household gets hit, make sure you have these essential meds and comfort items in your medicine cabinet.
Read full article →HealthTap launched a virtual care program to support sleep equipment suppliers and patients using PAP therapy. The post HealthTap Introduces Virtual Primary Care Program for DME Suppliers appeared first on MedCity News .
Read full article →Ultragenyx Pharmaceutical sold two priority review vouchers, each from an FDA approval of a gene therapy. Both therapies came from business deals and proceeds from the voucher sales put Ultragenyx in a better financial position to pursue yet another deal…
Read full article →The CEO of Compass Pathways said the company, whose psychedelic therapy is set for regulatory review this year, is prepared to “go slow before we go fast.”
Read full article →Three former FDA chiefs criticized the DOGE cuts to the agency, saying they robbed the FDA of institutional knowledge that will take years to restore.
Read full article →White House planned shift of research funding from universities to industry risks creating a drought in basic research, science leaders say
Read full article →(MedPage Today) -- PHOENIX -- Cardiovascular inflammation was highly prevalent among U.S. heart failure (HF) patients, a registry study found, illustrating the unmet need for good inflammation-targeting pharmacotherapy. In a subanalysis of POSEIDON...
Read full article →